Skip to main content
Clinical Trials/DRKS00015151
DRKS00015151
Recruiting
Not Applicable

Development of a Risk Prediciton Model for Chemotherapy-induced Nausea and Vomiting - EmRISK / NOGGO S18

OGGO e.V. Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie0 sites519 target enrollmentOctober 9, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
gynaecological cancer
Sponsor
OGGO e.V. Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie
Enrollment
519
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 9, 2018
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
OGGO e.V. Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie

Eligibility Criteria

Inclusion Criteria

  • Diagnosis with primary gynaecological cancer
  • \- Planned chemotherapy for at least three cycles, adjuvant and neoadjuvant (as standard of care)

Exclusion Criteria

  • \- Breast cancer
  • \- Chemotherapy has already started
  • \- Tumour of a different origin
  • \- Metastases in the central nervous system
  • \- Bowel obstruction/ Ileus/ Subileus

Outcomes

Primary Outcomes

Not specified

Similar Trials